Lnc-SNHG1 Activates the TGFBR2/SMAD3 and RAB11A/Wnt/ β-Catenin Pathway by Sponging MiR-302/372/373/520 in Invasive Pituitary Tumors
Conclusions: Our data suggest that lnc-SNHG1 promotes the progression of pituitary tumors and is a potential therapeutic target for invasive pituitary tumor.Cell Physiol Biochem 2018;48:1291 –1303
Source: Cellular Physiology and Biochemistry - Category: Cytology Source Type: research
More News: Biochemistry | Cancer | Cancer & Oncology | Cytology | Epithelial Cancer | Physiology | Pituitary Tumor | Study